Rungjirajittranon, T.; Siriwannangkul, T.; Kungwankiattichai, S.; Leelakanok, N.; Rotchanapanya, W.; Vittayawacharin, P.; Mekrakseree, B.; Kulchutisin, K.; Owattanapanich, W.
Clinical Outcomes of Acute Myeloid Leukemia Patients Harboring the RUNX1 Mutation: Is It Still an Unfavorable Prognosis? A Cohort Study and Meta-Analysis. Cancers 2022, 14, 5239.
https://doi.org/10.3390/cancers14215239
AMA Style
Rungjirajittranon T, Siriwannangkul T, Kungwankiattichai S, Leelakanok N, Rotchanapanya W, Vittayawacharin P, Mekrakseree B, Kulchutisin K, Owattanapanich W.
Clinical Outcomes of Acute Myeloid Leukemia Patients Harboring the RUNX1 Mutation: Is It Still an Unfavorable Prognosis? A Cohort Study and Meta-Analysis. Cancers. 2022; 14(21):5239.
https://doi.org/10.3390/cancers14215239
Chicago/Turabian Style
Rungjirajittranon, Tarinee, Theerapat Siriwannangkul, Smith Kungwankiattichai, Nattawut Leelakanok, Wannaphorn Rotchanapanya, Pongthep Vittayawacharin, Benjamaporn Mekrakseree, Kamolchanok Kulchutisin, and Weerapat Owattanapanich.
2022. "Clinical Outcomes of Acute Myeloid Leukemia Patients Harboring the RUNX1 Mutation: Is It Still an Unfavorable Prognosis? A Cohort Study and Meta-Analysis" Cancers 14, no. 21: 5239.
https://doi.org/10.3390/cancers14215239
APA Style
Rungjirajittranon, T., Siriwannangkul, T., Kungwankiattichai, S., Leelakanok, N., Rotchanapanya, W., Vittayawacharin, P., Mekrakseree, B., Kulchutisin, K., & Owattanapanich, W.
(2022). Clinical Outcomes of Acute Myeloid Leukemia Patients Harboring the RUNX1 Mutation: Is It Still an Unfavorable Prognosis? A Cohort Study and Meta-Analysis. Cancers, 14(21), 5239.
https://doi.org/10.3390/cancers14215239
